SMA Europe runs a yearly call for research projects which typically opens in July each year. This Call aims to address the following areas of SMA research:
- increase our understanding of the mechanisms of spinal muscular atrophy, in particular, understanding the SMN complex as it relates to the natural history of the disease,
- increase our understanding of the natural history of SMA,
- develop potential new therapies
- address bottlenecks which impair rapid transition from Basic Research to the Clinics (e.g.: Outcome measures, biomarkers, administration route of potential therapeutics)”
We are supported by a Scientific Advisory Board (SAB), composed of neuroscientists and neurologists with particular expertise in Spinal Muscular Atrophy research. The SAB identifies current and future priorities and through reviewing our grant applications, ensure that only the best science is funded.
Since 2008, SMA Europe has funded or committed to fund €4,446,557 to SMA research, in the following areas.
For more details, look at our: